Evidence map›Paper›PMID 9035102›Full record

ReviewNature biotechnology1997

Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines.

G Georgiou, C Stathopoulos, P S Daugherty, A R Nayak, B L Iverson, R Curtiss

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature biotechnology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed.

  1. Article
  2. Engineering of Surface Display Systems inBiotech (Basel (Switzerland)) · 2026
    Article
  3. Article
  4. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cancer therapy with antibodies.Nature reviews. Cancer · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

G GeorgiouDepartment of Chemical Engineering, University of Texas, Austin. gg@che.utexas.edu
C Stathopoulos
P S Daugherty
A R Nayak
B L Iverson
R Curtiss

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years there has been considerable progress towards the development of expression systems for the display of heterologous polypeptides and, to a lesser extent, oligosaccharides on the surface of bacteria or yeast. The availability of protein display vectors has in turn provided the impetus for a range of exciting technologies. Polypeptide libraries can be displayed in bacteria and screened by cell sorting techniques, thus simplifying the isolation of proteins with high affinity for ligands. Expression of antigens on the surface of nonvirulent microorganisms is an attractive approach to the development of high-efficacy recombinant live vaccines. Finally, cells displaying protein receptors or antibodies are of use for analytical applications and bioseparations.

Indexed as

Gene LibraryBacterial ProteinsCloning, MolecularForecastingGram-Negative BacteriaMembrane ProteinsPeptidesProtein EngineeringRecombinant ProteinsStaphylococcusVaccines, SyntheticYeastsBacterial ProteinsMembrane ProteinsPeptidesRecombinant ProteinsVaccines, Synthetic

Identifiers

PMID9035102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.